Premedium Pharmaceuticals

Gurugram, India
Manufactures pharmaceutical products for oncology, cardiology, and medical therapies.
Annual revenue $7.5M Latest available
Total funding - Funding intelligence
Employees 12 Tracked headcount
Investors - Known backers
Products 11 Services tracked
Competitors 8 Brand Intelligence

About Premedium Pharmaceuticals

Premedium Pharmaceuticals is a company based in Gurugram (India). It operates as a B2B. The company has 12 employees as of March 31, 2021. Premedium Pharmaceuticals offers products and services including Artepitant 150 IV Injection, Preciplatin 10 Mg, Preciplatin 50 Mg, Artetum Injection 1.5g, and Artezone Injection 1g. Premedium Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Gurugram, India
  • Employees 12 as on 31 Mar, 2021
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Premedium Pharmaceuticals Private Limited
  • Date of Incorporation 09 Oct, 2018
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $7.45 M (USD)
    0.04
    as on Mar 31, 2021
  • Net Profit
    -$1.29 M (USD)
    -129.43
    as on Mar 31, 2021
  • EBITDA
    -$774.37 K (USD)
    -43.91
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    12

    as on Mar 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Premedium Pharmaceuticals

Premedium Pharmaceuticals offers a comprehensive portfolio of products and services, including Artepitant 150 IV Injection, Preciplatin 10 Mg, Preciplatin 50 Mg, Artetum Injection 1.5g, and Artezone Injection 1g.

Product name locked
Category locked
Primary

IV treatment for chemotherapy-induced nausea and vomiting

Product name locked
Category locked
Locked

Medication for cancer therapy and tumor treatment

Product name locked
Category locked
Locked

Dosage for oncology and related medical uses

Product name locked
Category locked
Locked

Therapeutic injection for specific medical conditions

Product name locked
Category locked
Locked

Injection for healthcare and treatment purposes

Product name locked
Category locked
Locked

Advanced dosage for medical therapies

Product name locked
Category locked
Locked

Injection for pain or condition management

Product name locked
Category locked
Locked

Mono therapy for targeted health issues

Product name locked
Category locked
Locked

Dosage for specialized pharmaceutical needs

Product name locked
Category locked
Locked

Drug for various therapeutic applications

Product name locked
Category locked
Locked

High-dosage treatment option for patients

Funding Insights of Premedium Pharmaceuticals

Premium access

Detailed funding history for Premedium Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Premedium Pharmaceuticals

Investments
Premium access

Investment portfolio details for Premedium Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Premedium Pharmaceuticals

Premium access

Detailed financials for Premedium Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Premedium Pharmaceuticals Comparisons

Premedium Pharmaceuticals Primary company
Description
Manufactures pharmaceutical products for oncology, cardiolog...
Location
Gurugram, India
Founded Year
-
Annual Revenue
$7.45 M (USD)
Net Profit
-$1.29 M (USD)
EBITDA
-$774.37 K (USD)
Employees
12
As of 2021
Premium access

Peer comparison for Premedium Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Premedium Pharmaceuticals

Premedium Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Premedium Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Premedium Pharmaceuticals

Premium access

Complete news archive for Premedium Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Premedium Pharmaceuticals

Premedium Pharmaceuticals is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

As of Mar 31, 2021, the latest employee count at Premedium Pharmaceuticals is 12.

Annual revenue of Premedium Pharmaceuticals is $7.45M as on Mar 31, 2021.

Premedium Pharmaceuticals is an Indian company that produces and supplies innovative pharmaceutical products in sectors like oncology, biosimilars, cardiology, and anti-infectives. They focus on meeting global quality standards through manufacturing with international accreditations and serve healthcare providers worldwide from their base in Gurugram, India, addressing diverse medical needs.

Premedium Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Premedium Pharmaceuticals offers Artepitant 150 IV Injection, Preciplatin 10 Mg, Preciplatin 50 Mg, Artetum Injection 1.5g, and 6 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available